Universe Pharmaceuticals Inc - stock earnings
UPC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -5.4 million USD | 13.8 million USD |
| 2023Q2 | -715427 USD | 18.5 million USD |
| 2022Q4 | -10.5 million USD | 15.9 million USD |
| 2022Q2 | 1.7 million USD | 24.2 million USD |
| 2021Q4 | 4.2 million USD | 23.7 million USD |
| 2021Q1 | 7.1 million USD | 24.3 million USD |
| 2020Q3 | 1.9 million USD | 7.7 million USD |
| 2020Q2 | 1.9 million USD | 7.7 million USD |
| 2020Q1 | 1.9 million USD | 7.7 million USD |
| 2019Q4 | 1.9 million USD | 7.7 million USD |
| 2019Q3 | 1.9 million USD | 8.3 million USD |
| 2019Q2 | 1.9 million USD | 8.3 million USD |
| 2019Q1 | 1.9 million USD | 8.3 million USD |
| 2018Q4 | 1.9 million USD | 8.3 million USD |
| 2018Q3 | 1.9 million USD | 7.1 million USD |
| 2018Q2 | 1.9 million USD | 7.1 million USD |
| 2018Q1 | 1.9 million USD | 7.1 million USD |
| 2017Q4 | 1.9 million USD | 7.1 million USD |
UPC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -6.2 million USD | 32.3 million USD |
| 2022 | -8.7 million USD | 40.1 million USD |
| 2021 | 11.3 million USD | 48.0 million USD |
| 2020 | 7.6 million USD | 30.7 million USD |
| 2019 | 7.6 million USD | 33.2 million USD |
| 2018 | 7.6 million USD | 28.5 million USD |
UPC
Price: $2.18
52 week price:
Earnings Per Share: -1.70 USD
P/E Ratio: -0.64
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 21268
Market Capitalization: 6.6 million